New drug duo tested for Tough-to-Treat sarcoma
NCT ID NCT05926700
Summary
This study is testing whether a combination of two drugs, cadonilimab and anlotinib, can help control advanced soft tissue sarcoma that has continued to grow after standard first-line chemotherapy. It will involve about 27 adults to see if the treatment shrinks tumors and is safe. The goal is to find a new treatment option for people who have run out of standard choices.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Second Affiliated Hospital, Zhejiang University School of Medicine
RECRUITINGHangzhou, China
Contact
Conditions
Explore the condition pages connected to this study.